Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

BACKGROUND: Dabigatran is a novel oral anticoagulant approved for thromboprophylaxis in atrial fibrillation. Adoption patterns of this new agent in community practice are unknown. METHODS AND RESULTS: We studied patterns of dabigatran use among patients enrolled in the Outcomes Registry for Better I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Steinberg, Benjamin A., Holmes, DaJuanicia N., Piccini, Jonathan P., Ansell, Jack, Chang, Paul, Fonarow, Gregg C., Gersh, Bernard, Mahaffey, Kenneth W., Kowey, Peter R., Ezekowitz, Michael D., Singer, Daniel E., Thomas, Laine, Peterson, Eric D., Hylek, Elaine M.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3886732/
https://ncbi.nlm.nih.gov/pubmed/24275632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000535
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados